patient
Emerging Therapies in High-Risk MDS - 2024 Los Angeles Patient and Family Conference
ASH 2023 Update - Aplastic Anemia and PNH
Danicopan
VOYDEYA is a prescription medicine used along with ravulizumab or eculizumab to treat breakdown of red blood cells that takes place outside of blood vessels (extravascular hemolysis), in adults with
Recent FDA Approval of Danicopan for Patients with PNH
Dr. Caroline Piatek describes the purpose and use of this new drug approval for some patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria.
Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant
Damian was very active when routine blood work showed a problem. But Damian decided that going through treatment would be his mission, even if that meant two transplants. Listen here to his story.
Advances in Treating Aplastic Anemia
Biosimilars
What is a Biosimilar?
A biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication). Biosimilars are not generic versions of the original biologic.
Folate and Folic Acid
Folate is a B-vitamin that is found in fresh or lightly cooked green vegetables. It helps your